ParminderSinghMD

Oncology • Scottsdale, AZ

Physician

Join to view full profile

Dr. Singh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Singh's full profile

Already have an account?

Office
13400 E Shea Blvd
Scottsdale, AZ 85259
Phone+1 480-301-8000

Fax+1 602-301-8572

Education & Training

Westchester Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
Westchester Medical CenterResidency, Internal Medicine, 2006 - 2009
Maulana Azad Medical CollegeClass of 2002

Certifications & Licensure

CA State Medical License 2012 - Present
AZ State Medical License 2012 - 2027
TX State Medical License 2011 - 2019
American Board of Internal Medicine Medical Oncology

Clinical Trials

177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer Start of enrollment: 2009 Jun 01
Active, not recruiting
Phase 2
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer Start of enrollment: 2011 Sep 06
COMPLETED
PHASE1, PHASE2
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 08
ACTIVE_NOT_RECRUITING
PHASE3
Study of Oraxol and Pembrolizumab in Subjects With Advanced Solid Tumors Start of enrollment: 2018 Oct 25
Terminated
Phase 1
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Reducing Cancer Drug Cost: 3-Year Analysis of Automated Dose Rounding in Electronic Health Records.
Vishal S Shah, Clayton Irvine, Robert R McWilliams, Parminder Singh, Scott A Soefje
JCO Oncology Practice. 2025-03-01
COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results from the Locally Advanced or Metastatic Urothelial Carcinoma Cohorts.
Sumanta K Pal, Yohann Loriot, Andrea Necchi, Parminder Singh, Daniel Castellano
Journal of Clinical Oncology. 2025-02-18
16 citations
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma.
Andrea B Apolo, Karla V Ballman, Guru Sonpavde, Stephanie Berg, William Y Kim
The New England Journal of Medicine. 2025-01-02

Press Mentions

OncLive® Presents State of the Science Summit™ on Genitourinary CancersOctober 15th, 2019